Late cutaneous form of porphyria cutanea tarda in a 26-year-old man: a clinical case report
DOI:
https://doi.org/10.18203/2349-3933.ijam20261886Keywords:
Porphyria cutanea tarda, Uroporphyrinogen decarboxylase, Familial PCT, HCV, PhlebotomyAbstract
Porphyria cutanea tarda (PCT) is a rare form of enzymatic disorder of heme-biosynthesis pathway. Due to a defect of enzyme uroporphyrinogen decarboxylase (UROD) this disease occurs. Porphyria cutanea tarda can be sporadic and can be familial. Here, we are presenting a late cutaneous form of porphyria cutanea tarda in a 26-year-old male patient without any known triggers. The patient was diagnosed by genetic and laboratory testing and showed typical appearance of PCT. All the details of PCT from presentation of symptoms, complications, involvement of organs and diagnosis is discussed in this article. Furthermore, this article provides thorough discussion about PCT.
References
Leaf RK, Dickey AK. Porphyria cutanea tarda: a unique iron-related disorder. Hematology. 2024;2024(1):450-6.
Aarsand AK, Boman H, Sandberg S. Familial and Sporadic Porphyria Cutanea Tarda: Characterization and Diagnostic Strategies. Clin Chem. 2009;55(4):795-803.
Rossmann‐Ringdahl I, Olsson R. Porphyria Cutanea Tarda in a Swedish Population: Risk Factors and Complications. Acta Derm Venereol. 2005;85(4):337-41.
Cabezas Arteaga JE, Vieira FMJ, Silva Dos Reis VM. Experience in management of porphyria cutanea tarda in a tertiary referral Brazilian hospital from 2002 to 2017. Int J Dermatol. 2019;58(8):925-32.
Chaiyabutr C, Dawe R, Ibbotson SH, Clarke T, McGuire VA. Porphyria cutanea tarda in Scotland: underlying associations and treatment approaches. Int J Dermatol. 2024;63(12):1707-12.
Usta Atmaca H, Akbas F. Porphyria cutanea tarda: a case report. J Med Case Reports. 2019;13(1):17.
Muñoz-Santos C, Guilabert A, Moreno N, de Salamanca RE, Badenas C, Herrera E, et al. Familial and sporadic porphyria cutanea tarda: clinical and biochemical features and risk factors in 152 patients. Medicine (Baltimore). 2010;89(2):69-74.
Bulaj ZJ, Phillips JD, Ajioka RS, Franklin MR, Griffen LM, Guinee DJ, et al. Hemochromatosis genes and other factors contributing to the pathogenesis of porphyria cutanea tarda. Blood. 2000;95(5):1565-71.
Awad A, Nirenberg A, Sinclair R. Case Report: Treatment of porphyria cutanea tarda with low dose hydroxychloroquine. F1000Research. 2022;11:945.
Jalil S, Grady JJ, Lee C, Anderson KE. Associations Among Behavior-Related Susceptibility Factors in Porphyria Cutanea Tarda. Clin Gastroenterol Hepatol. 2010;8(3):297-302.
Frausto De La Cruz ER, Guzmán-Ramos JA, Hernández-Villanueva MF, Jiménez-López MA, Lazalde B. Genetic and clinical approach in acute intermittent porphyria and porphyria cutanea tarda. GSC Adv Res Rev. 2024;21(2):350-8.
Soufleris S, Moore M, Phillips JD, Ranganathan S, Magsino K. Novel UROD mutation for porphyria cutanea tarda, type 2: a case report. AME Case Rep. 2024;8:67.
Krivosheev AB, Kondratova MA, Gurazheva AA, Maksimov VN. HFE hemochromatosis gene polymorphism and porphyria cutanea tarda. Exp Clin Gastroenterol. 2023;(4):28-36.
Rossmann-Ringdahl I, Olsson R. Porphyria Cutanea Tarda: Effects and Risk Factors for Hepatotoxicity from High-dose Chloroquine Treatment. Acta Derm Venereol. 2007;87(5):401-5.
Pavlidou DC, Van Winckel G, Tran C. When Simple Phlebotomy Is the Cure: Porphyria Cutanea Tarda. J Gen Intern Med. 2022;37(13):3489-90.
Salameh H, Sarairah H, Rizwan M, Kuo YF, Anderson KE, Singal AK. Relapse of porphyria cutanea tarda after treatment with phlebotomy or 4-aminoquinoline antimalarials: a meta-analysis. Br J Dermatol. 2018;179(6):1351-7.
Lederhandler M, Chen L, Meehan SA, Brinster NK, Neimann AL. A case of porphyria cutanea tarda in the setting of hepatitis C infection and tobacco usage. Dermatol Online J. 2019;25(12):13030/qt0d46727.
Andersen J, Gjengedal E, Sandberg S, Råheim M. A skin disease, a blood disease or something in between? An exploratory focus group study of patients’ experiences with porphyria cutanea tarda. Br J Dermatol. 2015;172(1):223-9.
Prasad S, Vidhata V, Prasad S. Sight-threatening progressive corneo-scleral involvement in porphyria cutanea tarda. BMJ Case Rep. 2021;14(10):e245160.
Downloads
Published
How to Cite
Issue
Section
